Zhejiang Tianyu Pharmaceutical Co Ltd Capital Reinvestment Ratio
Zhejiang Tianyu Pharmaceutical Co Ltd capital reinvestment ratio. Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a Capital Reinvestment Ratio of 0.30x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥233.18 Million) in capital expenditures (CN¥70.00 Million). Check cash flow reinvestment rate of Zhejiang Tianyu Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2025)
Capital reinvestment ratio of Zhejiang Tianyu Pharmaceutical Co Ltd from 2013 to 2025. This chart tracks Zhejiang Tianyu Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. Also explore net asset momentum of Zhejiang Tianyu Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Zhejiang Tianyu Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2013–2025)
Zhejiang Tianyu Pharmaceutical Co Ltd capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see cash flow conversion of Zhejiang Tianyu Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.76x | CN¥473.57 Million | CN¥357.77 Million | ▲ +54.1% |
| 2024 | 0.49x | CN¥344.64 Million | CN¥168.95 Million | ▼ -39.7% |
| 2020 | 0.81x | CN¥622.18 Million | CN¥506.05 Million | ▼ -1.7% |
| 2019 | 0.83x | CN¥427.84 Million | CN¥354.10 Million | ▼ -63.8% |
| 2018 | 2.29x | CN¥78.57 Million | CN¥179.89 Million | ▲ +80.1% |
| 2017 | 1.27x | CN¥88.52 Million | CN¥112.54 Million | ▲ +95.0% |
| 2016 | 0.65x | CN¥164.74 Million | CN¥107.44 Million | ▼ -84.6% |
| 2015 | 4.24x | CN¥14.75 Million | CN¥62.59 Million | ▲ +326.7% |
| 2014 | 0.99x | CN¥80.44 Million | CN¥79.99 Million | ▼ -42.2% |
| 2013 | 1.72x | CN¥39.73 Million | CN¥68.31 Million | — |